患有原发性硬化胆管炎的患者的临床结局,有或没有炎症性肠病
1From Digestive Disease Research Center, Medical University of South Carolina, 96 Jonathan Lucas Street, Suite 908, Charleston, SC, 29425, USA.
Digestive diseases and sciences
|February 6, 2026
概括
患有原发性硬化性胆管炎 (PSC) 和炎症性肠病 (IBD) 的患者面临更糟糕的结果. 同时的IBD增加了PSC患者肝脏衰竭和胆管癌的风险.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 胃肠病学 胃肠病学
- 慢性肝脏疾病 慢性肝脏疾病
背景情况:
- 原发性硬化性胆管炎 (PSC) 是一种慢性肝病,经常与炎症性肠病 (IBD) 一起发生.
- 大约60-80%的PSC患者同时患有IBD,因此需要研究其对疾病进展的影响.
- 了解PSC和IBD之间的相互作用对于患者管理和结果预测至关重要.
研究的目的:
- 调查并发性炎症性肠病 (IBD) 对原发性硬化性脑膜炎 (PSC) 患者临床结果的影响.
- 为了比较患有IBD和没有IBD的PSC患者之间的肝脏相关失补偿,恶性瘤风险和死亡率.
主要方法:
- 使用TrinetX数据库进行的回顾性队列研究,包括被诊断患有PSC的18岁及以上的患者.
- 患者被分为两组:有IBD的PSC (PSC-IBD) 和没有IBD的PSC (隔离PSC).
- 使用倾向分数匹配 (PSM) 来平衡共变量,然后使用Cox比例危险建模来评估结果.
主要成果:
- 该研究确定了6,690名PSC患者;3,678人患有PSC-IBD,3,012人患有孤立的PSC. 在PSM之后,分析了1,714对.
- 与单独的PSC相比,PSC-IBD患者的肝脏相关失补偿 (HR 1.26),胆管癌 (HR 1.38) 和肝移植 (HR 1.50) 的风险明显更高.
- 在PSC-IBD组中,结肠直肠癌 (CRC) 的发生率明显更高 (HR 3.91),而整体死亡率没有显著差异. 性结肠炎患者比克罗恩病患者更严重的肝病.
结论:
- 同时的IBD显著恶化了被诊断为患有原发性硬化性脑膜炎的患者的临床结果.
- 患有IBD的PSC患者面临肝脏相关失补偿和发展胆管癌的风险较高.
- 这些发现强调了监测PSC患者同时存在IBD的不良结果的重要性.
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
1.1K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
Inflammatory Bowel Disease I: Ulcerative Colitis
1.0K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.0K
Inflammatory Bowel Disease V: Surgical Management
577
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
577
Inflammatory Bowel Disease IV: Pharmacological Management
663
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
663
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
786
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
786
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
821
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
821


